[Longterm psychosis and sultopride].
The action of sultopride was studied in patients with chronic psychosis during rehospitalization for a psychopathic episode. 22 patients (8 manic-depressive psychoses and 14 schizophrenias) were given sultopride as the sole therapy, in a daily dose of 4 vials. After symptomatic improvement therapy was continued by the oral route. Under these conditions, a satisfactory response was recorded in 81.8% of patients. These results are confronted with those previously obtained in a comparable group of patients given phenothazines. A statistically significant difference was found, with sultopride being more effective and acting more rapidly than phenothiazines.
D000328:Adult; D000077582:Amisulpride; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011618:Psychotic Disorders / Q000188:drug therapy*; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D013469:Sulpiride / Q000031:analogs & derivatives* / Q000627:therapeutic use
D011619:Psychotropic Drugs; D013469:Sulpiride; D000077582:Amisulpride
Psychoses au long cours et sultopride.